Our Company .

Solvotrin Therapeutics is an Irish healthcare development company that enhances established therapies through innovative science with patent protection.

Headquartered in Co. Cork, Ireland, Solvotrin has a team of 19 people with the R&D team members located at Trinity College Dublin.

Our Vision

To improve everyday health and wellness through scientific innovation, by providing practical and accessible product solutions.

Our Company

Solvotrin is a healthcare development company that enhances established therapies through innovative, patent-protected science, bringing them to market.

Our Mission

To create health and wellness solutions that empower people to live happier, healthier lives.

Founders & Investors .

Solvotrin Therapeutics was founded by CEO Pat O Flynn. Pat is a highly successful entrepreneur with over 20 years’ experience and an educational background in Engineering.

Founded in partnership with Professor Mark Ledwidge and Professor John Gilmer, Solvotrin works closely with a network of investors to drive the growth of Solvotrin Therapeutics. We blend research, data, technology, and investment to unlock opportunities and deliver strategic solutions across multiple markets.

Our Partners .

Bulgaria

Bulvax

China

Nuance Pharma

Germany

Eb Vertriebs

Greece

Bionat

Ireland

Pharmed Group

Malta

MGC Distributors

MMDS

Middle | East Africa

New Zealand

USL

Serbia

Proton

USA

The Market Performance Group

USA

Ortho Molecular

Our Strategy

Redesign

Redesign

Solvotrin redesigns essential medical and healthcare products.

Patent & Study

Patent & Study

This approach has produced two distinct patent-protected platforms.

Commercial Business

Commercial Business

Solvotrin has developed and successfully commercialised a range of innovative oral iron products, Active Iron.

Research & Development

Research & Development

Solvotrin has a family of novel compounds representing a high potential pipeline.

%}}